Anipryl is an oral tablet prescribed by veterinarians to control the clinical signs of canine cognitive dysfunction syndrome (CDS) and of uncomplicated pituitary-dependent Addison's Disease (PDH). Since this medication is a selective monoamine oxidase -B inhibitor, it may enhance catecholamine neuroactivity and increase dopamine levels in dogs. Unlike other prescription medications, Anipryl does not require laboratory tests for treatment and it can be given with your canine companion’s favorite food.
Anipryl tablets are indicated for the control of clinical signs associated with canine cognitive dysfunction syndrome (CDS) and control of clinical signs associated with uncomplicated canine pituitary-dependent hyperadrenocorticism (PDH).
Possible Side Effects
Contact your veterinarian if your dog experiences restlessness/agitation, vomiting, disorientation, diarrhea, diminished hearing, possible drug interaction (weakness, confusion, incoordination and “seizure like” activity while being treated concurrently with metronidazole, prednisone, and trimethoprim sulfa), increase in destructive behavior in a dog with separation anxiety, anorexia, anemia, stiffness and polydipsia.
Drug & Food Interactions
Concurrent use of Anipryl with ephedrine or potential MAO inhibitors, such as amitraz, is not recommended.
Anipryl is not recommended for other behavior problems such as aggression. The safety and efficacy of Anipryl has not been evaluated in dogs with debilitating systemic diseases other than PDH.
See all items by Anipryl